PTC Therapeutics (BH3.F) Q1 2026 Earnings

Feb 19Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1.42
2
5.43
8.85

Details

Expected EPS
0.0876069936
Actual EPS
-1.418331
Surprise EPS
-1.51
Surprise Percent
-1,718.97%

Description

⁨PTC Therapeutics⁩ (⁦BH3.F⁩) has reported earnings of ⁦-1.418331⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts